|1.||Hankinson, Susan E: 5 articles (12/2009 - 08/2003)|
|2.||Rohan, Thomas E: 5 articles (07/2009 - 01/2002)|
|3.||Colditz, Graham A: 4 articles (12/2009 - 12/2003)|
|4.||Norkus, Edward P: 4 articles (10/2008 - 05/2002)|
|5.||Hunter, David J: 4 articles (02/2007 - 12/2003)|
|6.||Willett, Walter C: 4 articles (02/2007 - 02/2004)|
|7.||JACC Study Group: 3 articles (02/2014 - 01/2003)|
|8.||Ozasa, Kotaro: 3 articles (02/2014 - 01/2003)|
|9.||Watanabe, Yoshiyuki: 3 articles (02/2014 - 01/2003)|
|10.||Wolk, Alicja: 3 articles (04/2010 - 02/2007)|
05/01/1999 - "These data suggest that plasma levels of alpha-carotene and gamma-tocopherol may represent markers of atherosclerosis in humans. "
05/01/1999 - "Lipophilic antioxidants in blood plasma as markers of atherosclerosis: the role of alpha-carotene and gamma-tocopherol."
01/01/2000 - "No association with atherosclerosis was observed for quartiles of serum concentrations of alpha-carotene, beta-carotene, lutein, and zeaxanthin. "
02/01/2004 - "These findings suggest that higher levels of plasma oxygenated carotenoids (lutein, zeaxanthin, beta-cryptoxanthin) and alpha-carotene may be protective against early atherosclerosis."
05/01/1999 - "In order to assess whether the levels of lipophilic antioxidants in human plasma can discriminate between subjects with and without atherosclerosis, we measured the lipophilic antioxidants alpha-tocopherol, gamma-tocopherol, alpha-carotene, beta-carotene and ubiquinol-10 in plasma of 34 patients with coronary heart disease (CHD) and in 40 control subjects. "
|2.||Chronic Obstructive Pulmonary Disease (COPD)
08/01/2001 - "Plasma vitamin A, alpha-carotene, beta-carotene, lycopene, lutein/zeaxanthin, and vitamin E were depressed at enrollment and increased by day 7. Multivariate analyses showed that higher plasma lycopene concentrations at enrollment were associated with clearance of parasitemia between enrollment and day 3 (odds ratio = 1.46, 95% confidence interval = 1.07-2.06, per 0.10 micromol/L of lycopene). "
|4.||Squamous Cell Neoplasms (Squamous Cell Cancer)
01/01/1995 - "Oral administration of alpha-carotene (0.05% in drinking water) significantly decreased the mean number of lung tumors per mouse. "
01/01/1995 - "In the two-stage mouse skin carcinogenesis model (initiator, 7,12-dimethylbenz[a]anthracene; promoter, 12-O-tetradecanoylphorbol-13-acetate), topical application of alpha-carotene at a 200 nmol dose per painting twice a week significantly decreased the mean number of skin tumors per mouse. "
12/01/1992 - "alpha-Carotene, but not beta-carotene, reduced the number of lung tumors per mouse to about 30% of that in the control group (P < 0.001, Student's t test). "
01/15/2005 - "The inverse association observed with alpha-carotene and breast cancer was greater for invasive cancers with nodal metastasis. "
10/01/2000 - "Colorful cancer prevention: alpha-carotene, lycopene, and lung cancer."
|5.||beta Carotene (Betacarotene)
|7.||Vitamin A (Retinol)
|8.||Ascorbic Acid (Vitamin C)